Abstract
Staphylococcus aureus is a common human pathogen, and over the past 90 years has been increasingly recognized as an important cause of pneumonia. The epidemiology of staphylococcal pneumonia has changed over this time period, and S. aureus is now a frequent cause of both community-acquired and hospital-acquired pneumonia including ventilator- associated pneumonia. This article reviews the important changes in the epidemiology and microbiology of S. aureus, the clinical features of S. aureus pneumonia, and considerations in antibiotic therapy for this disease.
Keywords: Staphylococcus aureus, pneumonia
Current Respiratory Medicine Reviews
Title: Pneumonia Caused by Staphylococcus aureus
Volume: 5 Issue: 1
Author(s): Sarah D. Haessler and Richard B. Brown
Affiliation:
Keywords: Staphylococcus aureus, pneumonia
Abstract: Staphylococcus aureus is a common human pathogen, and over the past 90 years has been increasingly recognized as an important cause of pneumonia. The epidemiology of staphylococcal pneumonia has changed over this time period, and S. aureus is now a frequent cause of both community-acquired and hospital-acquired pneumonia including ventilator- associated pneumonia. This article reviews the important changes in the epidemiology and microbiology of S. aureus, the clinical features of S. aureus pneumonia, and considerations in antibiotic therapy for this disease.
Export Options
About this article
Cite this article as:
Haessler D. Sarah and Brown B. Richard, Pneumonia Caused by Staphylococcus aureus, Current Respiratory Medicine Reviews 2009; 5 (1) . https://dx.doi.org/10.2174/157339809787354056
DOI https://dx.doi.org/10.2174/157339809787354056 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections
Anti-Infective Agents Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology Current Developments in Anti-Fungal Agents
Current Medicinal Chemistry - Anti-Infective Agents Linezolid in Children: Recent Patents and Advances
Recent Patents on Anti-Infective Drug Discovery Case Report: Culture-negative Prosthetic Valve Endocarditis
Current Cardiology Reviews Proteomics Analysis: A Powerful Tool to Identify Proteome Phenotype and Proteome Signature in Enterococcus faecalis
Current Proteomics Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms
Current Topics in Medicinal Chemistry Special Features of Gram-Positive Bacterial Eradication by Photosensitizers
Recent Patents on Anti-Infective Drug Discovery Infection and Hemodialysis Access: An Updated Review.
Infectious Disorders - Drug Targets Malignant Hypertension: A Rare Problem or is it Underdiagnosed?
Current Vascular Pharmacology Novel Strategies for Combating Pathogenic Biofilms Using Plant Products and Microbial Antibiosis
Current Pharmaceutical Biotechnology Catheter Related Line Sepsis Resulting from Mycobacterium <i>chelonae</i> Infection in an Immunocompromised Host
Infectious Disorders - Drug Targets Adenotonsillar Disease
Recent Patents on Inflammation & Allergy Drug Discovery Use of Oritavancin (Novel New Lipoglycopeptide) in the Treatment of Prosthetic Joint Infections (PJI): A Possible Alternative Novel Approach to a Difficult Problem
Infectious Disorders - Drug Targets Ethanol and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Autoimmune Fibrotic Adverse Reactions in One-Year Treatment with Cabergoline for Women with Prolactinoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Surgical Treatment of Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension
Current Pharmaceutical Design Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Nano-zinc Coordination with the Ligands of Carboplatin, Oxaliplatin and Nedaplatin. Synthesis, Characterization and Biological Properties
Letters in Organic Chemistry Antimicrobial Precious-Metal Nanoparticles and their Use in Novel Materials
Recent Patents on Food, Nutrition & Agriculture